The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
Open accessAbstract
As people age, iron deposits in different areas of the brain may impair normal cognitive function and behavior. Abnormal iron metabolism generates hydroxyl radicals through the Fenton reaction, triggers oxidative stress reactions, damages cell lipids, protein and DNA structure and function, and ultimately leads to cell death. There is an imbalance in iron homeostasis in Alzheimer's disease (AD). Excessive iron contributes to the deposition of β-amyloid and the formation of neurofibrillary tangles, which in turn, promotes the development of AD. Therefore, iron-targeted therapeutic strategies have become a new direction. Iron chelators, such as desferoxamine, deferiprone, deferasirox, and clioquinol, have received a great deal of attention and have obtained good results in scientific experiments and some clinical trials. Given the limitations and side effects of the long-term application of traditional iron chelators, alpha-lipoic acid and lactoferrin, as self-synthesized naturally small molecules, have shown very intriguing biological activities in blocking Aβ-aggregation, tauopathy and neuronal damage. Despite a lack of evidence for any clinical benefits, the conjecture that therapeutic chelation, with a special focus on iron ions, is a valuable approach for treating AD remains widespread.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: The Hepcidin-Binding Site on Ferroportin Is Evolutionarily Conserved
Domenico, I. D., Nemeth, E., Nelson, J. M., Phillips, J. D., Ajioka, R. S., Kay, M. S., Kushner, J. P., Ganz, T., Ward, D. M., & Kaplan, J. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.002 · Cited by 128
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Ferroptosis: Death by Lipid Peroxidation
Yang, W. S., & Stockwell, B. R. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.014 · Cited by 3,088
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Ferroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
The role of iron in brain ageing and neurodegenerative disorders
Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70117-6 · Cited by 1,819
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Self-citationSeiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.005 · Cited by 1,470
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 2×
“Another study showed that 15-month-old APP Tg2576AD mice treated with CQ demonstrated a significantly reduced number and sizes of SPs in the brain compared with those of the sham-treated littermates (Cherny et al., 2001).”
BackgroundResultProliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Cohen, S. I. A., Linse, S., Luheshi, L. M., Hellstrand, E., White, D. A., Rajah, L., Otzen, D. E., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218402110 · Cited by 1,440
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?
Klein, W. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01749-5 · Cited by 989
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988
Hambright, W. S., Fonseca, R. S., Chen, L., Na, R., & Ran, Q. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.021 · Cited by 851
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., & Perry, V. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2614-05.2005 · Cited by 768
Al-Atrache, Z., Cader, A., & Appelt, D. M. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.894 · Cited by 765
Intramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?
Gerlach, M., Ben‐Shachar, D., Riederer, P., & Youdim, M. B. H. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63030793.x · Cited by 703
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
Tuo, Q.-Z., Lei, P., Jackman, K. A., Li, X.-L., Xiong, H., Li, X.-L., Liuyang, Z.-Y., Roisman, L., Zhang, S.-T., Ayton, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.171 · Cited by 700
Duce, J. A., Tsatsanis, A., Cater, M. A., James, S. A., Robb, E., Wikhe, K., Leong, S. L., Perez, K., Johanssen, T., Greenough, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.08.014 · Cited by 676
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Lei, P., Ayton, S., Finkelstein, D. I., Spoerri, L., Ciccotosto, G. D., Wright, D. K., Wong, B. X. W., Adlard, P. A., Cherny, R. A., Lam, L. Q., et al. (2012) · Nature Medicine · doi:10.1038/nm.2613 · Cited by 594
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Rogers, J. T., Randall, J. D., Cahill, C. M., Eder, P. S., Huang, X., Gunshin, H., Leiter, L., McPhee, J., Sarang, S. S., Utsuki, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207435200 · Cited by 551
The biology and chemistry of high-valent iron–oxo and iron–nitrido complexes
Hohenberger, J., Ray, K., & Meyer, K. (2012) · Nature Communications · doi:10.1038/ncomms1718 · Cited by 544
Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins
METZ-BOUTIGUE, M.-H., JOLLES, J., MAZURIER, J., SCHOENTGEN, F., LEGRAND, D., SPIK, G., MONTREUIL, J., & JOLLES, P. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08607.x · Cited by 538
Characterization of Superoxide-producing Sites in Isolated Brain Mitochondria
Kudin, A. P., Bimpong-Buta, N. Y.-B., Vielhaber, S., Elger, C. E., & Kunz, W. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310341200 · Cited by 508
Chen, L., Hambright, W. S., Na, R., & Ran, Q. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.680090 · Cited by 498
Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495
Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration
Abdalkader, M., Lampinen, R., Kanninen, K. M., Malm, T. M., & Liddell, J. R. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00466 · Cited by 423
Selective iron chelation in Friedreich ataxia: biologic and clinical implications
Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409
Preventing Alzheimer’s Disease
Selkoe, D. J. (2012) · Science · doi:10.1126/science.1228541 · Cited by 376
Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Müller, M., et al. (1997) · Diabetes · doi:10.2337/diab.46.9.1481 · Cited by 371
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
Nitration of Tyrosine 10 Critically Enhances Amyloid β Aggregation and Plaque Formation
Kummer, M. P., Hermes, M., Delekarte, A., Hammerschmidt, T., Kumar, S., Terwel, D., Walter, J., Pape, H.-C., König, S., Roeber, S., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.001 · Cited by 336
Ayton, S., Faux, N. G., Bush, A. I., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2015) · Nature Communications · doi:10.1038/ncomms7760 · Cited by 327
Connor, J. R., Snyder, B. S., Arosio, P., Loeffler, D. A., & LeWitt, P. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020717.x · Cited by 317 · cited 1×
“Iron Regulation in the Brain According to autopsy reports, total iron deposition in the human brain is positively related to age and contains high concentrations of iron in the basal ganglia of the putamen, globus pallidus, and substantia nigra (Connor et al., 1995), whereas the cerebral cortex, the brainstem and cere…”
BackgroundDixon, S. J. (2017) · Immunological Reviews · doi:10.1111/imr.12533 · Cited by 314
Yamamoto, A., Shin, R., Hasegawa, K., Naiki, H., Sato, H., Yoshimasu, F., & Kitamoto, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.t01-1-01061.x · Cited by 313
The Metal Theory of Alzheimer's Disease
Bush, A. I. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129011 · Cited by 305
Zhang, Y.-H., Wang, D.-W., Xu, S.-F., Zhang, S., Fan, Y.-G., Yang, Y.-Y., Guo, S.-Q., Wang, S., Guo, T., Wang, Z.-Y., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.001 · Cited by 304
Self-citationZHANG, W.-J., & FREI, B. (2001) · The FASEB Journal · doi:10.1096/fj.01-0260com · Cited by 300
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294
Callaghan, M. F., Freund, P., Draganski, B., Anderson, E., Cappelletti, M., Chowdhury, R., Diedrichsen, J., FitzGerald, T. H. B., Smittenaar, P., Helms, G., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.008 · Cited by 292
GOODMAN, L. (1953) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-195308000-00001 · Cited by 286
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline
Ayton, S., Fazlollahi, A., Bourgeat, P., Raniga, P., Ng, A., Lim, Y. Y., Diouf, I., Farquharson, S., Fripp, J., Ames, D., et al. (2017) · Brain · doi:10.1093/brain/awx137 · Cited by 279
Iron and Alzheimer’s Disease: An Update on Emerging Mechanisms
Lane, D. J. R., Ayton, S., & Bush, A. I. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179944 · Cited by 276
The role of transporters in cellular heme and porphyrin homeostasis
KRISHNAMURTHY, P., XIE, T., & SCHUETZ, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.001 · Cited by 260
Wright, R. O., & Baccarelli, A. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.12.2809 · Cited by 257
Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant?
Ou, P., Tritschler, H. J., & Wolff, S. P. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00116-h · Cited by 251
Yamamoto, A., Shin, R., Hasegawa, K., Naiki, H., Sato, H., Yoshimasu, F., & Kitamoto, T. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01061.x · Cited by 246
Brain iron metabolism: Neurobiology and neurochemistry
Ke, Y., & Qian, Z. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236
Ha, C., Ryu, J., & Park, C. B. (2007) · Biochemistry · doi:10.1021/bi7000032 · Cited by 231
Zhou, Z. D., & Tan, E.-K. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0218-4 · Cited by 222
Ramos, P., Santos, A., Pinto, N. R., Mendes, R., Magalhães, T., & Almeida, A. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2013.08.001 · Cited by 221
Metal Chelation as a Potential Therapy for Alzheimer's Disease
CUAJUNGCO, M. P., FAGÉT, K. Y., HUANG, X., TANZI, R. E., & BUSH, A. I. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06938.x · Cited by 215
The pivotal role of astrocytes in the metabolism of iron in the brain
Dringen, R., Bishop, G. M., Koeppe, M., Dang, T. N., & Robinson, S. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9375-0 · Cited by 209
Guo, C., Wang, T., Zheng, W., Shan, Z.-Y., Teng, W.-P., & Wang, Z.-Y. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.05.009 · Cited by 199
Self-citationGuo, C., Wang, P., Zhong, M.-L., Wang, T., Huang, X.-S., Li, J.-Y., & Wang, Z.-Y. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.005 · Cited by 189
Self-citationMetal Ion Effects on Aβ and Tau Aggregation
Kim, A. C., Lim, S., & Kim, Y. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010128 · Cited by 186
Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment
van Bergen, J. M. G., Li, X., Hua, J., Schreiner, S. J., Steininger, S. C., Quevenco, F. C., Wyss, M., Gietl, A. F., Treyer, V., Leh, S. E., et al. (2016) · Scientific Reports · doi:10.1038/srep35514 · Cited by 180
α-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats
Panigrahi, M., Sadguna, Y., Shivakumar, B. R., Kolluri, S. V. R., Roy, S., Packer, L., & Ravindranath, V. (1996) · Brain Research · doi:10.1016/0006-8993(96)00009-1 · Cited by 176
Cortical iron reflects severity of Alzheimer's disease
van Duijn, S., Bulk, M., van Duinen, S. G., Nabuurs, R. J. A., van Buchem, M. A., van der Weerd, L., & Natté, R. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161143 · Cited by 172
Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders
Mena, N. P., Urrutia, P. J., Lourido, F., Carrasco, C. M., & Núñez, M. T. (2015) · Mitochondrion · doi:10.1016/j.mito.2015.02.001 · Cited by 172
Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.
Kawamata, T., Tooyama, I., Yamada, T., Walker, D. G., & McGeer, P. L. (1993) · PubMed · Cited by 171
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., Tanzi, R. E., et al. (1995) · Neurology · doi:10.1212/wnl.45.7.1323 · Cited by 169
Telling, N. D., Everett, J., Collingwood, J. F., Dobson, J., van der Laan, G., Gallagher, J. J., Wang, J., & Hitchcock, A. P. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.07.014 · Cited by 169
Everett, J. L., Céspedes, E., Shelford, L. R., Exley, C., Collingwood, J. F., Dobson, J., van der Laan, G., Jenkins, C., Arenholz, E., & Telling, N. D. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0165 · Cited by 165
Myhre, O., Utkilen, H., Duale, N., Brunborg, G., & Hofer, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/726954 · Cited by 164
Chronic dietary α-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice
Quinn, J. F., Bussiere, J. R., Hammond, R. S., Montine, T. J., Henson, E., Jones, R. E., & Stackman, R. W. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.014 · Cited by 160
Plascencia‐Villa, G., Ponce, A., Collingwood, J. F., Arellano-Jiménez, M. J., Zhu, X., Rogers, J. T., Betancourt, I., José–Yacamán, M., & Perry, G. L. (2016) · Scientific Reports · doi:10.1038/srep24873 · Cited by 158
Reynolds, M. R., Reyes, J. F., Fu, Y., Bigio, E. H., Guillozet-Bongaarts, A. L., Berry, R. W., & Binder, L. I. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2143-06.2006 · Cited by 156
A potential pathogenetic role of iron in Alzheimer's disease
Silvestri, L., & Camaschella, C. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00356.x · Cited by 146
Metal exposure and Alzheimer’s pathogenesis
Liu, G., Huang, W., Moir, R. D., Vanderburg, C. R., Lai, B. C. H., Peng, Z., Tanzi, R. E., Rogers, J. T., & Huang, X. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.12.011 · Cited by 144
Moon, Y., Han, S., & Moon, W. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151037 · Cited by 144
Iron chelation in the treatment of neurodegenerative diseases
Dušek, P., Schneider, S. A., & Aaseth, J. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.03.010 · Cited by 141
Iron Imports. I. Intestinal iron absorption and its regulation
Frazer, D. M., & Anderson, G. J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00220.2005 · Cited by 139
Du, L., Zhao, Z., Cui, A., Zhu, Y., Zhang, L., Liu, J., Shi, S., Fu, C., Han, X., Gao, W., et al. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00194 · Cited by 139
Self-citationGrossi, C., Francese, S., Casini, A., Rosi, M. C., Luccarini, I., Fiorentini, A., Gabbiani, C., Luigi Messori, A., Moneti, G., & Casamenti, F. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1063 · Cited by 136
Du, F., Qian, Z., Luo, Q., Yung, W., & Ke, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8847-x · Cited by 135
Zinc, Carnosine, and Neurodegenerative Diseases
Kawahara, M., Tanaka, K.-I., & Kato-Negishi, M. (2018) · Nutrients · doi:10.3390/nu10020147 · Cited by 134
Everett, J. L., Collingwood, J. F., Tjhin, V. T., Brooks, J., Lermyte, F., Plascencia‐Villa, G., Hands-Portman, I., Dobson, J., Perry, G. L., & Telling, N. D. (2018) · Nanoscale · doi:10.1039/c7nr06794a · Cited by 130
Amit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H., & Mandel, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-8627rev · Cited by 126 · cited 1×
“In addition to Aβ peptides, iron can bind to tau protein, induce tau protein phosphorylation, and aggregate phosphorylated tau protein, whereas this phenomenon can be reversed by iron chelators (Amit et al., 2008).”
BackgroundMetal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease
Wang, P., & Wang, Z. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.003 · Cited by 126
Self-citationGiampietro, R., Spinelli, F., Contino, M., & Colabufo, N. A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00841 · Cited by 126
Bulk, M., Abdelmoula, W. M., Nabuurs, R. J. A., van der Graaf, L. M., Mulders, C. W. H., Mulder, A. A., Jost, C. R., Koster, A. J., van Buchem, M. A., Natté, R., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.017 · Cited by 125
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
Cárdenas-Aguayo, M. D. C., Gómez-Virgilio, L., DeRosa, S., & Meraz-Ríos, M. A. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500148z · Cited by 120
Guo, C., Yang, Z., Zhang, S., Chai, R., Han, X., Zhang, Y., Li, J., & Wang, Z. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.8 · Cited by 119
Self-citationMetal Binding Dictates Conformation and Function of the Amyloid Precursor Protein (APP) E2 Domain
Dahms, S. O., Könnig, I., Roeser, D., Gührs, K., Mayer, M., Kaden, D., Multhaup, G., & Than, M. E. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.057 · Cited by 118
Wong, A. O., Dukić-Stefanović, S., Gasic‐Milenkovic, J., Schinzel, R., Wiesinger, H., Riederer, P., & Münch, G. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01820.x · Cited by 117
Perry, G. L., Taddeo, M. A., Petersen, R. B., Castellani, R. J., Harris, P. L. R., Siedlak, S. L., Cash, A., Liu, Q., Nunomura, A., Atwood, C., et al. (2003) · BioMetals · doi:10.1023/a:1020731021276 · Cited by 116
Hepcidin, an emerging and important player in brain iron homeostasis
Vela, D. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1399-5 · Cited by 116
Cahill, C. M., Lahiri, D. K., Huang, X., & Rogers, J. T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.12.001 · Cited by 113
Suh, J. H., Moreau, R. F., Heath, S.-H. D., & Hagen, T. M. (2005) · Redox Report · doi:10.1179/135100005x21624 · Cited by 113
Nakamura, T., & Lipton, S. A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3570 · Cited by 108
Park, D., Yang, Y., Bae, D. K., Lee, S. H., Yang, G., Kyung, J., Kim, D., Choi, E., Lee, S. W., Kim, G., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.026 · Cited by 107
Garrick, M. D., & Garrick, L. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.018 · Cited by 107
Bierhaus, A., Chevion, S., Chevion, M., Hofmann, M. A., Quehenberger, P., Illmer, T., Luther, T., Berentshtein, E., Tritschler, H., Muller, M., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.9.1481 · Cited by 106
Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease
Daher, R., Manceau, H., & Karim, Z. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.006 · Cited by 99
Sting of Alzheimer's failures offset by upcoming prevention trials
Mullard, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3842 · Cited by 98
Arivazhagan, P., Shila, S., Kumaran, S., & Panneerselvam, C. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00015-3 · Cited by 97
Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse
Lei, P., Ayton, S., Appukuttan, A. T., Volitakis, I., Adlard, P. A., Finkelstein, D. I., & Bush, A. I. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.015 · Cited by 93
Precuneus amyloid burden is associated with reduced cholinergic activity in Alzheimer disease
Ikonomović, M. D., Klunk, W. E., Abrahamson, E. E., Wuu, J., Mathis, C. A., Scheff, S. W., Mufson, E. J., & DeKosky, S. T. (2011) · Neurology · doi:10.1212/wnl.0b013e3182231419 · Cited by 89
Sripetchwandee, J., Wongjaikam, S., Krintratun, W., Chattipakorn, N., & Chattipakorn, S. C. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.003 · Cited by 88
Kunt, T., Forst, T. M., Wilhelm, A., Tritschler, H., PFUETZNER, A., Harzer, O., Engelbach, M., ZSCHAEBITZ, A., Stofft, E., & Beyer, J. (1999) · Clinical Science · doi:10.1042/cs0960075 · Cited by 87
Evidence that iron accelerates Alzheimer’s pathology: a CSF biomarker study
Ayton, S., Diouf, I., & Bush, A. I. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2017-316551 · Cited by 87
Iron Levels Modulate α‐Secretase Cleavage of Amyloid Precursor Protein
Bodovitz, S., Falduto, M. T., Frail, D. E., & Klein, W. L. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64010307.x · Cited by 86
Xu, H., Wang, Y., Song, N., Wang, J., Jiang, H. F., & Xie, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00455 · Cited by 86
Xie, L., Zheng, W. H., Xin, N., Xie, J., Wang, T., & Wang, Z. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.05.016 · Cited by 84
Self-citationLactoferrin during lactation protects the immature hypoxic‐ischemic rat brain
van de Looij, Y., Ginet, V., Chatagner, A., Toulotte, A., Somm, E., Hüppi, P. S., & Sizonenko, S. V. (2014) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.138 · Cited by 84
Differential effects of age and history of hypertension on regional brain volumes and iron
Rodrigue, K. M., Haacke, E. M., & Raz, N. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.068 · Cited by 83
Du, F., Qian, C., Qian, Z., Wu, X., Xie, H., Yung, W., & Ke, Y. (2011) · Glia · doi:10.1002/glia.21166 · Cited by 82
Fine, J. M., Baillargeon, A. M., Renner, D. B., Hoerster, N., Tokarev, J. V., Colton, S., Pelleg, A. R., Andrews, A. W., Sparley, K., Krogh, K., et al. (2012) · Experimental Brain Research · doi:10.1007/s00221-012-3101-0 · Cited by 81
Kamalinia, G., Khodagholi, F., Atyabi, F., Amini, M., Shaerzadeh, F., Sharifzadeh, M. S., & Dinarvand, R. (2013) · Molecular Pharmaceutics · doi:10.1021/mp4002014 · Cited by 81
Kawahara, M., Kato-Negishi, M., & Tanaka, K. (2017) · Metallomics · doi:10.1039/c7mt00046d · Cited by 80
Guo, C., Zhang, Y., Wang, T., Zhong, M., Yang, Z., Hao, L.-J., Chai, R., & Zhang, S. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00104 · Cited by 80
Self-citationBergen, J. M. G. V., Li, X., Quevenco, F. C., Gietl, A. F., Treyer, V., Meyer, R., Buck, A., Kaufmann, P. A., Nitsch, R. M., van Zijl, P. C. M., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.03.021 · Cited by 80
Iron Chelation in Thalassemia Major
Borgna‐Pignatti, C., & Marsella, M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.10.001 · Cited by 77
Radioiodinated clioquinol as a biomarker for β‐amyloid: Zn2+ complexes in Alzheimer's disease
Opazo, C., Luza, S., Villemagne, V. L., Volitakis, I., Rowe, C. C., Barnham, K. J., Altschul, D., Masters, C. L., Cherny, R. A., & Bush, A. I. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00196.x · Cited by 76
5 The Present Status of Chelating Agents in Medicine
May, P. M., & Bulman, R. A. (1983) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70220-0 · Cited by 76
(2000) · PubMed · Cited by 75
Fe2+binding on amyloid β-peptide promotes aggregation
Boopathi, S., & Kolandaivel, P. (2016) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25075 · Cited by 75
Tahmasebinia, F., & Emadi, S. (2017) · BioMetals · doi:10.1007/s10534-017-0005-2 · Cited by 74
Zhao, Y., Raichle, M. E., Wen, J., Benzinger, T. L. S., Fagan, A. M., Hassenstab, J. J., Vlassenko, A. G., Luo, J., Cairns, N. J., Christensen, J. J., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.12.026 · Cited by 73
The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease
Fava, A., Pirritano, D., Plastino, M., Cristiano, D., Puccio, G., Colica, C., Ermio, C., Bartolo, M. D., Mauro, G. F., & Bosco, D. (2013) · Journal of Neurodegenerative Diseases · doi:10.1155/2013/454253 · Cited by 71
Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load
Goozee, K. G., Chatterjee, P., James, I., Shen, K., Sohrabi, H. R., Asih, P. R., Dave, P., ManYan, C., Taddei, K., Ayton, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.146 · Cited by 71
Health status and work burden of Alzheimer patients’ informal caregivers
Colvez, A., Joël, M.-È., Ponton-Sanchez, A., & Royer, A.-C. (2002) · Health Policy · doi:10.1016/s0168-8510(01)00215-9 · Cited by 69
Li, X., Lei, P., Tuo, Q., Ayton, S., Li, Q., Moon, S., Volitakis, I., Liu, R., Masters, C. L., Finkelstein, D. I., et al. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0378-2 · Cited by 67
Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease
O’Callaghan, J. M., Holmes, H. E., Powell, N. M., Wells, J. A., Ismail, O., Harrison, I. F., Siow, B. M., Johnson, R. A., Ahmed, Z., Fisher, A., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.08.003 · Cited by 65
Alpha lipoic acid changes iron uptake and storage in lens epithelial cells
Goralska, M., Dackor, R. T., Holley, B. L., & McGahan, M. C. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(02)00307-x · Cited by 63
Hirata, Y., Yamada, C., Ito, Y., Yamamoto, S., Nagase, H., Oh‐hashi, K., Kiuchi, K., Suzuki, H., Sawada, M., & Furuta, K. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.03.015 · Cited by 63
Wang, T., Wang, C., Shan, Z., Teng, W., & Wang, Z. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111874 · Cited by 61
Self-citationDwivedi, N., Flora, G., Kushwaha, P. K., & Flora, S. J. S. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.10.010 · Cited by 61
Pretorius, E., Vermeulen, N., Bester, J., Lipiński, B., & Kell, D. B. (2013) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.762082 · Cited by 60
Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease
Sternberg, Z., Hu, Z., Sternberg, D. S., Waseh, S., Quinn, J. F., Wild, K., Kaye, J. A., Zhao, L., & Garrick, M. D. (2017) · Aging and Disease · doi:10.14336/ad.2016.0811 · Cited by 60
Fonte, J., Miklossy, J., Atwood, C., & Martins, R. N. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3206 · Cited by 54
Banerjee, P., Sahoo, A., Anand, S., Ganguly, A., Righi, G., Bovicelli, P., Saso, L., & Chakrabarti, S. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8328-4 · Cited by 52
Wang, D., Hui, Y., Peng, Y., Tang, L., Jin, J., He, R., Li, Y., Zhang, S., Li, L., Zhou, Y. L., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140567 · Cited by 51
Distribution study of orally administered lipoic acid in rat brain tissues
Chng, H. T., New, L., Neo, A. H., Goh, C. W., Browne, E. R., & Chan, E. C. Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.025 · Cited by 51
Wang, L., Sato, H., Zhao, S., & Tooyama, I. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.079 · Cited by 50
The role of iron in neurodegenerative disorders: insights and opportunities with synchrotron light
Collingwood, J. F., & Davidson, M. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00191 · Cited by 48
Ferritin light chain interacts with PEN-2 and affects γ-secretase activity
Li, X., Liu, Y., Zheng, Q., Yao, G., Peng, C., Bu, G., Xu, H., & Zhang, Y. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.05.018 · Cited by 47
Morse, L. J., Payton, S. M., Cuny, G. D., & Rogers, J. T. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:1:129 · Cited by 46
Peters, D. G., Pollack, A. N., Cheng, K. C., Sun, D., Saido, T. C., Haaf, M., Yang, Q. X., Connor, J. R., & Meadowcroft, M. D. (2018) · Metallomics · doi:10.1039/c8mt00004b · Cited by 45
Nmnat2 Attenuates Tau Phosphorylation Through Activation of PP2A
Cheng, X., Zhao, K.-P., Jiang, X., Du, L., Li, X., Ma, Z., Yao, J., Luo, Y., Duan, D.-X., Wang, J., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122173 · Cited by 40
Essential Trace Metals and Brain Function
Takeda, A. (2004) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.124.577 · Cited by 40
Getting the iron out: Phlebotomy for Alzheimer’s disease?
Dwyer, B. E., Zacharski, L. R., Balestra, D. J., Lerner, A. J., Perry, G. L., Zhu, X., & Smith, M. A. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.12.029 · Cited by 37
Billings, J. L., Hare, D. J., Nurjono, M., Volitakis, I., Cherny, R. A., Bush, A. I., Adlard, P. A., & Finkelstein, D. I. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00305 · Cited by 37
Aliaga, M. E., Carrasco‐Pozo, C., López‐Alarcón, C., Olea‐Azar, C., & Speisky, H. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.10.064 · Cited by 34
Chen, Y., Chen, W.-Y., Huang, X., Xu, Y., & Zhang, H. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.113 · Cited by 31
de Freitas, R. M. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0041-6 · Cited by 27
Amyloid A β 42 , a promoter of magnetite nanoparticle formation in Alzheimer’s disease
Tahirbegi, I. B., Pardo, W. A., Alvira, M., Mir, M., & Samitier, J. (2016) · Nanotechnology · doi:10.1088/0957-4484/27/46/465102 · Cited by 27
Guo, J., Gao, S., Liu, Z., Zhao, R., & Yang, X. (2016) · Lipids · doi:10.1007/s11745-016-4185-2 · Cited by 22
Effect of ferric citrate on amyloid‐beta peptides behavior
Galante, D., Cavallo, E., Perico, A., & D’Arrigo, C. (2018) · Biopolymers · doi:10.1002/bip.23224 · Cited by 21
Fe(II) formation after interaction of the amyloid β-peptide with iron-storage protein ferritin
Balejčíková, L., Šipošová, K., Kopčanský, P., & Šafařı́k, I. (2018) · Journal of Biological Physics · doi:10.1007/s10867-018-9498-3 · Cited by 20
Guerreiro, C. C., Silva, B. D. R., Crespo, Â. C., Marques, L., Costa, S., Timóteo, Â., Marcelino, E., Maruta, C., Vilares, A., Matos, M., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.07.017 · Cited by 19
Valverde, F., López‐Mascaraque, L., & Carlos, J. (1990) · Journal of Neurocytology · doi:10.1007/bf01188035 · Cited by 19
Pharmacoeconomic considerations of treating patients with advanced Parkinson's disease
Reese, J. P., Dams, J., Winter, Y., Balzer‐Geldsetzer, M., Oertel, W. H., & Dodel, R. C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.677435 · Cited by 18
Nanoscale Imaging Reveals Big Role for Iron in Alzheimer’s Disease
Ayton, S., James, S., & Bush, A. I. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.10.002 · Cited by 15
Lactoferrin in the myeloproliferative disorders: a search for granulopoietic regulator defects
Brown, R. D., RICKARD, K. A., & KRONENBERG, H. (1985) · British Journal of Haematology · doi:10.1111/j.1365-2141.1985.tb07356.x · Cited by 13
Impairment of bile salt-dependent lipase secretion in human pancreatic tumoral SOJ-6 cells
Caillol, N., Pasqualini, E., Lloubès, R., & Lombardo, D. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20001215)79:4<583::aid-jcb70>3.0.co;2-9 · Cited by 13
New insights into intestinal iron absorption
Hörl, W. H. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn458 · Cited by 6
Cited by
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723
Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation
Huat, T. J., Camats-Perna, J., Newcombe, E. A., Valmas, N., Kitazawa, M., & Medeiros, R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.018 · Cited by 470
Molecular mechanisms of ferroptosis and their involvement in brain diseases
Costa, I., Barbosa, D. J., Benfeito, S., Silva, V., Chavarria, D., Borges, F., Remião, F., & Silva, R. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108373 · Cited by 402
Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications
Gromadzka, G., Tarnacka, B., Flaga, A., & Adamczyk, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239259 · Cited by 339
Reich, N., & Hölscher, C. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.970925 · Cited by 248
Metadata
- Authors
- Liu, J.-L., Fan, Y.-G., Yang, Z.-S., Wang, Z.-Y., & Guo, C.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-09-10
- Volume
- 12
- Pages
- 632-632
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2891312833
- Cited by
- 284
- References
- 166
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.